{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12872",
      "entity_text" : "MAP",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:53477739",
      "entity_text" : "Vasopressin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Vasopressin at a dose of 0.03 units / minute should be considered to decrease the dose of norepinephrine or augment the MAP with goal MAP> = 65 mm Hg.",
  "reading_complete" : "2020-08-05T19:19:36Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:17:34Z",
  "trigger" : "augment",
  "evidence" : [ "Vasopressin at a dose of 0.03 units/minute should be considered to decrease the dose of norepinephrine or augment the MAP" ],
  "pmc_id" : "5877904",
  "score" : 0
}